This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cancer Patients Struggling To Afford Care And Pay Bills In Troubled Economy, According To New Poll

"While improving access to care for all Americans will help to make tremendous strides in our ability to reduce death and suffering related to cancer, sustained funding for cancer research is also critical to a comprehensive approach to defeating this disease," said Christopher W. Hansen, president of ACS CAN.  "An estimated 1.4 million people will be diagnosed with cancer this year and research holds the key to advances in early detection and treatment so this disease becomes one we can live well with, rather than die from."

ACS CAN is calling on Congress to sustain funding provided last year in the American Recovery and Reinvestment Act and provide the National Institutes of Health with $35.2 billion, including $5.8 billion for the National Cancer Institute in the FY 2011 Labor, Health and Human Services appropriations bill.

The poll was conducted May 21-June 2 among 1,011 registered voters nationwide by Lake Research Partners and Bellwether Research and Consulting.  For a summary of the polling results, visit http://bit.ly/ablkXR.  

ACS CAN, the nonprofit, nonpartisan advocacy affiliate of the American Cancer Society, supports evidence-based policy and legislative solutions designed to eliminate cancer as a major health problem. ACS CAN works to encourage elected officials and candidates to make cancer a top national priority. ACS CAN gives ordinary people extraordinary power to fight cancer with the training and tools they need to make their voices heard. For more information, visit www.acscan.org.

SOURCE American Cancer Society Cancer Action Network

Copyright 2009 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
3 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
AAPL $125.43 0.72%
FB $85.77 -0.04%
GOOG $520.60 -0.18%
YHOO $39.29 0.98%
TSLA $268.36 2.40%

Markets

DOW 17,618.77 +22.42 0.13%
S&P 500 2,067.13 +9.49 0.46%
NASDAQ 4,995.3970 +36.9290 0.74%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs